Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22
Phase 41

Trial Status

Completed4

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT00929578Phase 2Completed
Fluphenazine Hydrochloride for Psoriasis
Psoriasis
Principalinvestigator
NCT00930592Completed
Peds Metabolic Syndrome in Psoriasis
Metabolic SyndromePsoriasis
Principalinvestigator
NCT00931242Phase 2Completed
Study of Apremilast in Atopic or Contact Dermatitis
Allergic Contact DermatitisAtopic Dermatitis
Principalinvestigator
NCT00932113Phase 4Completed
Mechanism of Action Study for Psoriasis
Psoriasis
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Tufts Medical Center, Department of Dermatology

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT00929578Phase 2PrincipalInvestigator

Fluphenazine Hydrochloride for Psoriasis

Psoriasis
Completed
NCT00930592PrincipalInvestigator

Peds Metabolic Syndrome in Psoriasis

Metabolic SyndromePsoriasis
Completed
NCT00931242Phase 2PrincipalInvestigator

Study of Apremilast in Atopic or Contact Dermatitis

Allergic Contact DermatitisAtopic Dermatitis
Completed
NCT00932113Phase 4PrincipalInvestigator

Mechanism of Action Study for Psoriasis

Psoriasis
Completed

All 4 trials loaded